| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BD Antiviral monoclonal antibodies
J06BD02 Motavizumab
D06621 Motavizumab (USAN/INN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
RSV F protein
D06621 Motavizumab (USAN/INN)
|